{
    "Trade/Device Name(s)": [
        "First Sign Drug of Abuse Cup Test",
        "First Sign Drug of Abuse Dip Card Test"
    ],
    "Submitter Information": "W.H.P.M., Inc.",
    "510(k) Number": "K142353",
    "Predicate Device Reference 510(k) Number(s)": [
        "K052115"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DIO",
        "DKZ",
        "LDJ"
    ],
    "Summary Letter Date": "October 7, 2014",
    "Summary Letter Received Date": "August 21, 2014",
    "Submission Date": "August 15, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.3250",
        "21 CFR 862.3100",
        "21 CFR 862.3870"
    ],
    "Regulation Name(s)": [
        "Cocaine & Cocaine Metabolite test system",
        "Amphetamine Test System",
        "Cannabinoid Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine (d-amphetamine)",
        "Cocaine (Benzoylecgonine)",
        "Marijuana (11-nor-\u03949-THC-9-COOH)"
    ],
    "Specimen Type(s)": [
        "Human Urine"
    ],
    "Specimen Container(s)": [
        "Urine cup"
    ],
    "Instrument(s)/Platform(s)": [
        "Dip Card",
        "Cup"
    ],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow chromatographic immunoassay",
        "Competitive binding"
    ],
    "Methodologies": [
        "Immunoassay",
        "Lateral flow"
    ],
    "Submission Type(s)": [
        "Kit",
        "Test Device"
    ],
    "Document Summary": "FDA 510(k) summary for First Sign Drug of Abuse Cup Test and Dip Card Test for qualitative detection of amphetamine, cocaine, and marijuana in human urine",
    "Indications for Use Summary": "Qualitative detection of amphetamine, cocaine, and marijuana in human urine for over-the-counter and prescription use; provides preliminary results with confirmatory testing recommended",
    "fda_folder": "Toxicology"
}